Imbruvica 140 mg/1
Ibrutinib · CAPSULE · Pharmacyclics LLC
Imbruvica (ibrutinib) is an oral kinase inhibitor capsule used to treat certain types of blood cancers, including chronic lymphocytic leukemia and lymphomas. This prescription medication works by blocking proteins that help cancer cells grow and survive.
Key Facts
- Brand Name
- Imbruvica
- Generic Name
- Ibrutinib
- NDC Code (Product)
57962-140- Manufacturer
- Pharmacyclics LLC
- Strength
- 140 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA205552
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/13/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is Imbruvica used for?
Imbruvica (ibrutinib) is an oral kinase inhibitor capsule used to treat certain types of blood cancers, including chronic lymphocytic leukemia and lymphomas. This prescription medication works by blocking proteins that help cancer cells grow and survive.
Is Imbruvica a controlled substance?
Imbruvica is not classified as a controlled substance by the DEA.
What is the generic name for Imbruvica?
The generic name for Imbruvica is Ibrutinib. There are no other listed brand versions of Ibrutinib.
What is the NDC code for Imbruvica 140 mg/1?
The NDC (National Drug Code) for Imbruvica 140 mg/1 is 57962-140, listed by Pharmacyclics LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)